Transplantation outcomes in patients with primary hyperoxaluria: a systematic review
Elisabeth L. Metry(Emma Kinderziekenhuis), Sander F. Garrelfs(Emma Kinderziekenhuis), Rutger J. Ploeg(University of Oxford), Vianda S Stel(Amsterdam UMC Location University of Amsterdam), Hessel Peters‐Sengers(Amsterdam Neuroscience), Jaap W. Groothoff(University of Amsterdam), Liza M. M. van Dijk(Emma Kinderziekenhuis), Michiel J.S. Oosterveld(Emma Kinderziekenhuis)
Cited by 43
Related Papers
An introduction to inverse probability of treatment weighting in observational research
|Clinical Kidney Journal|2021|877
CKD Prevalence Varies across the European General Population
|Journal of the American Society of Nephrology|2015|588
Lumasiran, an RNAi Therapeutic for Primary Hyperoxaluria Type 1
|New England Journal of Medicine|2021|505
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe
|Kidney International|2020|502
New classification of donation after circulatory death donors definitions and terminology
|Transplant International|2016|419